Mechanisms of resistance to SHP2 inhibition

被引：0

作者：

Wei, Wei ^{[1
]}

Geer, Mitchell ^{[1
]}

Guo, Xinyi ^{[2
]}

Sanjana, Neville ^{[1
]}

Neel, Benjamin G. ^{[1
]}

机构：

[1] NYU Grossman Sch Med, New York, NY USA

[2] NYU, New York, NY USA

来源：

CANCER RESEARCH | 2022年 / 82卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

659

引用

页数：1

共 50 条

[1] Allosteric SHP2 phosphatase inhibition: Multiple mechanisms and chemotypes
LaMarche, Matthew J.
Bagdanoff, Jeff
Acker, Mike
Chen, Ying-Nan
Chan, Homan
Dore, Michael
Firestone, Brant
Fodor, Michelle
Garcia-Fortanet, Jorge
Hentemann, Murphy
Kato, Mitsunori
Koenig, Robert
La Bonte, Laura
Liu, Shumei
Mohseni, Movarid
Ntaganda, Rukundo
Sarver, Patrick
Smith, Troy
Sendzik, Martin
Stams, Travis
Spence, Stan
Towler, Chris
Wang, Hongyun
Wang, Ping
Williams, Sarah
Chen, Zhouliang
Hao, Huaixiang
Liu, Gang
Liu, Chen
McNeill, Eric
Yu, Bing
CANCER RESEARCH, 2019, 79 (13)
[2] Sidestepping SHP2 inhibition
Popescu, Bogdan
Shannon, Kevin
JOURNAL OF EXPERIMENTAL MEDICINE, 2023, 220 (05):
[3] Allosteric inhibition of SHP2 phosphatase
Fortanet, Jorge Garcia
Chen, Christine
Chen, Yingnan
Chen, Zhouliang
Deng, Zhan
Firestone, Brant
Fekkes, Peter
Fodor, Michelle
Fortin, Pascal
Fridrich, Cary
Grunenfelder, Denise
Ho, Samuel
Kang, Zhao
Karki, Rajesh
Kato, Mitsunori
Keen, Nick
Labonte, Laura
Larrow, Jay
Lenoir, Francois
Liu, Gang
Liu, Shumei
Lombardo, Franco
Majumdar, Dyuti
Meyer, Matthew
Palermo, Mark
Perez, Lawrence
Pu, Minying
Ramsey, Timothy
Sellers, William
Shultz, Michael
Stams, Travis
Towler, Chris
Wang, Ping
Williams, Sarah
Zhang, Ji-Hu
LaMarche, Matthew
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
[4] Dual Allosteric Inhibition of SHP2 Phosphatase
Fodor, Michelle
Price, Edmund
Wang, Ping
Lu, Hengyu
Argintaru, Andreea
Chen, Zhouliang
Glick, Meir
Hao, Huai-Xiang
Kato, Mitsunori
Koenig, Robert
LaRochelle, Jonathan R.
Liu, Gang
McNeill, Eric
Majumdar, Dyuti
Nishiguchi, Gisele A.
Perez, Lawrence B.
Paris, Gregory
Quinn, Christopher M.
Ramsey, Timothy
Sendzik, Martin
Shultz, Michael David
Williams, Sarah L.
Stams, Travis
Blacklow, Stephen C.
Acker, Michael G.
LaMarche, Matthew J.
ACS CHEMICAL BIOLOGY, 2018, 13 (03) : 647 - 656
[5] Structural reorganization of SHP2 by oncogenic mutations and implications for oncoprotein resistance to allosteric inhibition
LaRochelle, Jonathan R.
Fodor, Michelle
Vemulapalli, Vidyasiri
Mohseni, Morvarid
Wang, Ping
Stams, Travis
LaMarche, Matthew J.
Chopra, Rajiv
Acker, Michael G.
Blacklow, Stephen C.
NATURE COMMUNICATIONS, 2018, 9
[6] SHP2 Inhibition Prevents Adaptive Resistance to MEK Inhibitors in Multiple Cancer Models
Fedele, Carmine
Ran, Hao
Diskin, Brian
Wei, Wei
Jen, Jayu
Geer, Mitchell J.
Araki, Kiyomi
Ozerdem, Ugur
Simeone, Diane M.
Miller, George
Neel, Benjamin G.
Tang, Kwan Ho
CANCER DISCOVERY, 2018, 8 (10) : 1237 - 1249
[7] Structural reorganization of SHP2 by oncogenic mutations and implications for oncoprotein resistance to allosteric inhibition
Jonathan R. LaRochelle
Michelle Fodor
Vidyasiri Vemulapalli
Morvarid Mohseni
Ping Wang
Travis Stams
Matthew J. LaMarche
Rajiv Chopra
Michael G. Acker
Stephen C. Blacklow
Nature Communications, 9
[8] Inhibition of SHP2 abolishes mammary tumorigenesis in mice
Matalka, Fatimah
Hartman, Zachary
Agazie, Yehenew M.
CANCER RESEARCH, 2011, 71
[9] The mechanisms of SHP2 activation in cancer and neurodevelopmental disorder
Liu, Yonglan
Zhang, Mingzhen
Zhang, Wengang
Jang, Hyunbum
Nussinov, Ruth
CANCER RESEARCH, 2023, 83 (07)
[10] FGFR- and EGFR-driven SHP2 activation displays differential sensitivity to allosteric SHP2 inhibition
Hao, Huaixiang
Lu, Hengyu
Liu, Chen
LaMarche, Matthew
Engelman, Jeffrey A.
Hammerman, Peter S.
Caponigro, Giordano
CANCER RESEARCH, 2019, 79 (13)

← 1 2 3 4 5 →